サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541265

酸素療法市場レポート：製品、用途、最終用途、地域別、2024～2032年

Oxygen Therapy Market Report by Product, Application, End Use, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
酸素療法市場レポート：製品、用途、最終用途、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の酸素療法市場規模は2023年に189億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに335億米ドルに達し、2024～2032年の間に6.4％の成長率（CAGR）を示すと予測しています。COPD、喘息、間質性肺疾患、肺炎などの呼吸器疾患の有病率の増加、入院治療と比較して費用対効果が高いことから在宅医療へのニーズの高まり、世界の高齢化の進展などが市場を牽引する主要要因となっています。

酸素療法市場分析

主要市場促進要因：喘息、慢性閉塞性肺疾患（COPD）、間質性肺疾患、肺炎などの疾病が増加しており、酸素療法の需要を喚起しています。これは高齢者人口の増加とともに、酸素療法市場の成長を刺激する重要な要因の一つとなっています。

主要市場動向：在宅医療は患者に利便性を提供するため、呼吸器疾患を患う人々の間で新たな動向となっています。病院での治療には費用がかかるが、在宅医療は費用の節約に役立つため、非常に好まれています。

地理的動向：北米が市場をリードしているのは、喫煙や環境汚染による呼吸器疾患の有病率が上昇しているためです。しかし、アジア太平洋では高齢者人口が増加しており、この地域が酸素療法の新興市場になりつつあります。

競合情勢：酸素療法業界の主要市場参入企業には、Allied Healthcare Products Inc.、Becton Dickinson and Company、DeVilbiss Healthcare LLC（Drive Medical Inc.）、Fisher &Paykel Healthcare Limited、General Electric Company、Getinge AB、Hersill SL、Invacare Corporation、Koninklijke Philips N.V.、Smiths Group plc、Tecno-Gaz S.p.A.、Teleflex Incorporatedなどがあります。

課題と機会：同市場は、いくつかの地域における医療アクセスの制限などの課題に直面する一方で、遠隔医療統合や遠隔モニタリング機能などの技術的進歩における機会にも遭遇しています。

酸素療法市場傾向

在宅医療の動向

IMARC Groupのレポートによると、世界の在宅医療市場は2023年に3,922億米ドルに達します。多くの患者、特に高齢者や慢性疾患を持つ患者は、病院や介護施設といった施設よりも、自宅でケアを受ける快適さと利便性を好みます。こうした傾向が在宅酸素療法オプションの需要を牽引しています。在宅医療は入院治療よりも手ごろな価格で受けられることが多く、入院期間や関連コストを削減できます。在宅医療機器は軽量で使い方が簡単であり、患者の可動性と自由を維持できるため、在宅酸素療法はより現実的で魅力的なものとなっています。COPDや肺線維症を含む多くの慢性呼吸器疾患では、長期にわたる酸素治療が必要です。在宅医療は様々な疾患の継続的かつ一貫した管理を可能にし、患者の治療へのアドヒアランスと治療成績を向上させる。

呼吸器疾患の有病率の増加

2023年に世界保健機関（WHO）のウェブサイトに掲載された記事によると、世界第3位の死因は慢性閉塞性肺疾患（COPD）で、2019年には323万人が死亡するといいます。COPD、喘息、間質性肺疾患、肺炎は非常に一般的であり、これらの疾患の症状を管理するために酸素療法が必要です。呼吸器疾患は有害な影響を及ぼし、長期的な管理のみが患者の治療に役立つため、酸素療法は慢性呼吸器疾患を管理しながら血液中の酸素濃度を適切に維持する上で非常に有用です。

高齢化

高齢者はCOPD、肺気腫、肺炎などの呼吸器疾患にかかりやすく、酸素療法はこれらの疾患を管理する唯一の方法です。高齢者は、高血圧、心臓病、糖尿病など、呼吸器疾患を悪化させる慢性疾患をいくつも抱えている可能性があり、酸素療法の需要が高まっています。高齢者の免疫システムは弱いため、いくつかの感染症を引き寄せ、重篤な呼吸器疾患につながる可能性があります。国際通貨基金（IMF）の電子図書館のウェブサイトに掲載された記事によると、2050年までに80歳以上の高齢者の世界の割合は4倍になり、ほぼ5％になると予想されています。

酸素療法市場セグメンテーション

IMARC Groupは、2024～2032年までの世界、地域、国レベルの予測とともに、市場の各セグメントにおける主要動向の分析を提供しています。製品別、用途別、最終用途別に市場を分類しています。

製品別内訳

酸素源装置が市場シェアの大半を占める

本レポートでは、製品別に市場を詳細に区分・分析しています。これには、酸素源装置（酸素ボンベ、酸素濃縮装置、液体酸素装置、PAP装置）と酸素供給装置（酸素マスク、鼻カニューレ、ベンチュリーマスク、非再呼吸マスク、バッグバルブマスク、CPAPマスク、その他）が含まれます。同レポートによると、酸素源装置は最大のセグメントを占めています。

酸素源機器は患者に必要な酸素を供給するため、酸素治療には不可欠です。これらの装置がなければ、酸素を必要とする患者に酸素を供給することは困難であり、市場にとって必要不可欠なものとなっています。これらの機器は病院、クリニック、在宅医療施設など様々な場面で利用されています。その適応性の高さと多くの医療現場での必要性が、強い需要の原動力となっています。ポータブルで軽量な設計、より優れた効率性、ユーザーフレンドリーな機能など、酸素源機器の継続的な進歩や改良が酸素療法市場の概観に影響を与えています。

用途別内訳

慢性閉塞性肺疾患が業界の最大シェアを占める

本レポートでは、用途別の市場の詳細な区分と分析も提供しています。これには、慢性閉塞性肺疾患、喘息、閉塞性睡眠時無呼吸症候群、呼吸窮迫症候群、嚢胞性線維症、肺炎、その他が含まれます。報告書によると、慢性閉塞性肺疾患が最大の市場シェアを占めています。

COPDの発症率の高さは、酸素療法を必要とする患者数の多さに直結しており、最も一般的な用途セグメントとなっています。COPDは進行性の慢性疾患であり、時間の経過とともに悪化し、長期的なケアと治療が必要となります。COPD患者は、症状をコントロールし、生活の質を維持するために、継続的または断続的な酸素療法を必要とします。酸素治療は呼吸困難や激しい息切れを緩和し、COPD管理に不可欠なものとなるため、酸素療法市場洞察にプラスの影響を与えます。

最終用途別内訳

在宅医療は主要市場セグメントを占める

本レポートでは、最終用途別に市場を詳細に区分・分析しています。これには在宅医療と病院が含まれます。同レポートによると、在宅医療は最大のセグメントです。

患者は病院やクリニックよりも快適な自宅で治療を受けることを好みます。在宅医療は、患者が習慣を継続し、慣れ親しんだ環境で過ごすことを可能にし、全体的なQOLとケアに対する満足度を向上させる。一般的に、在宅医療は入院治療よりも費用がかからないです。長期入院の必要がなく、医療費も抑えられ、医療機関への負担も軽減されます。この費用対効果は、患者と医療専門家の双方に魅力的です。医療技術の進歩、特に携帯型酸素濃縮器やその他の家庭用酸素供給システムの進歩は、患者の自宅での酸素療法へのアクセスを簡素化しました。これらの機器はより使いやすく、効率的で、持ち運びしやすくなっており、家庭用としての魅力を高めています。

地域別内訳

北米が市場をリードし、最大の酸素療法市場シェアを占める

本レポートでは、北米（米国、カナダ）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、ラテンアメリカ（ブラジル、メキシコ、その他）、中東アフリカを含む主要地域市場についても包括的に分析しています。報告書によると、北米は酸素療法の最大地域市場です。

北米はCOPD、喘息、睡眠時無呼吸症候群などの呼吸器疾患の有病率が高く、これらは高齢化、喫煙、環境汚染などの要因によって引き起こされます。高度な医療インフラ、最先端医療技術の普及、医療保険償還に関する法規制が、市場を牽引しています。さらに、在宅医療の人気が高まり、携帯可能で使い勝手のよい酸素療法機器が入手可能になったことで、患者が自宅で病気を管理することが容易になりました。さらに、この地域で事業を展開する主要企業は、酸素のようなガスの貯蔵容量の拡大に注力しています。例えば、Chart Industriesは2024年、アラバマ州セオドアにジャンボ極低温タンク製造施設をグランドオープンすると発表しました。

競合情勢

この市場調査レポートは、市場の競合情勢についても包括的な分析を行っています。主要企業の詳細プロファイルも提供しています。酸素療法業界の主要市場参入企業には、Allied Healthcare Products Inc.、Becton Dickinson and Company、DeVilbiss Healthcare LLC（Drive Medical Inc.）、Fisher &Paykel Healthcare Limited、General Electric Company、Getinge AB、Hersill SL、Invacare Corporation、Koninklijke Philips N.V.、Smiths Group plc、Tecno-Gaz S.p.A.、Teleflex Incorporatedなどがあります。

（なお、これは主要企業の一部一覧であり、完全なリストは報告書に記載されている）

酸素治療市場の主要企業は、市場での存在感を高め、製品提供を改善し、変化する顧客ニーズを満たすことを目的とした様々な戦略的活動に積極的に取り組んでいます。酸素療法市場のリーダー企業は研究開発（R&D）活動に投資し、先進的な機能を備え、携帯性が向上し、効率が高まった画期的な酸素治療器を製造しています。さらに、重要な企業は、製品ポートフォリオを強化し、地理的範囲を拡大し、新規市場に参入するために、合併・買収（M&A）や提携を頻繁に利用しています。例えば、工業用ガス、特殊ガス、エネルギー転換市場向けのプロセス技術と機器のエンジニアリングと製造の世界的リーダーであるChart Industries, Inc.は、2023年にKPS Capital Partners, LP（以下「KPS」）の関連会社から、ミッションクリティカルな空気・ガスハンドリング製品とサービスの世界的大手プロバイダーであるHowdenの買収を完了しました。また、呼吸器の健康や酸素治療の利点に関する知識を向上させるためのマーケティングや教育イニシアティブに取り組んでいる企業もあります。

酸素療法市場ニュース

2023年7月、Emersonは、ASCO（TM）Series 588 Stationary Oxygen Concentrator Manifoldを発表しました。これは、呼吸療法機器の設計を最適化し、製品の市場投入スピードを加速するために設計された、医療業界初のターンキー・マニホールドソリューションです。

本レポートで扱う主要質問

  • 世界の酸素療法市場の規模は？
  • 2024～2032年における酸素療法市場の世界市場成長率は？
  • 世界の酸素療法市場を牽引する主要要因は何か
  • 世界の酸素療法市場に対するCOVID-19の影響は？
  • 酸素療法市場の製品別内訳は？
  • 世界の酸素療法市場の用途別内訳は？
  • 酸素療法市場の世界における最終用途別の内訳は？
  • 酸素療法市場の世界における主要地域は？
  • 酸素療法市場の世界における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の酸素療法市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 酸素源装置
    • 市場動向
    • 主要セグメント
      • 酸素ボンベ
      • 酸素濃縮器
      • 液体酸素装置
      • PAP装置
    • 市場予測
  • 酸素供給装置
    • 市場動向
    • 主要セグメント
      • 酸素マスク
      • 鼻カニューレ
      • ベンチュリマスク
      • 非再呼吸マスク
      • バッグバルブマスク
      • CPAPマスク
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 慢性閉塞性肺疾患
  • 喘息
  • 閉塞性睡眠時無呼吸
  • 呼吸窮迫症候群
  • 嚢胞性線維症
  • 肺炎
  • その他

第8章 市場内訳：最終用途別

  • 在宅医療
  • 病院

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allied Healthcare Products Inc.
    • Becton Dickinson and Company
    • DeVilbiss Healthcare LLC（Drive Medical Inc.）
    • Fisher & Paykel Healthcare Limited
    • General Electric Company
    • Getinge AB
    • Hersill SL
    • Invacare Corporation
    • Koninklijke Philips N.V
    • Smiths Group plc
    • Tecno-Gaz S.p.A.
    • Teleflex Incorporated
図表

List of Figures

  • Figure 1: Global: Oxygen Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygen Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oxygen Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Oxygen Therapy Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Oxygen Therapy Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oxygen Therapy Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Oxygen Therapy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Oxygen Therapy (Oxygen Source Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Oxygen Therapy (Oxygen Source Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Oxygen Therapy (Oxygen Delivery Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Oxygen Therapy (Oxygen Delivery Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Oxygen Therapy (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Oxygen Therapy (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Oxygen Therapy (Cystic Fibrosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Oxygen Therapy (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Oxygen Therapy (Pneumonia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Oxygen Therapy (Pneumonia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Oxygen Therapy (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Oxygen Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Oxygen Therapy (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Oxygen Therapy (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Oxygen Therapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Oxygen Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Oxygen Therapy Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Oxygen Therapy Industry: SWOT Analysis
  • Figure 80: Global: Oxygen Therapy Industry: Value Chain Analysis
  • Figure 81: Global: Oxygen Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygen Therapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Oxygen Therapy Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Oxygen Therapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oxygen Therapy Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Oxygen Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Oxygen Therapy Market: Competitive Structure
  • Table 7: Global: Oxygen Therapy Market: Key Players
目次
Product Code: SR112024A3847

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032. The growing prevalence of respiratory diseases like COPD, asthma, interstitial lung disease, and pneumonia, rising need for home healthcare as it is more cost-effective compared to inpatient care, and increasing aging population worldwide are some of the major factors driving the market.

Oxygen Therapy Market Analysis:

Major Market Drivers: Diseases like asthma, COPD, interstitial lung disease, and pneumonia are increasing, which is catalyzing the demand for oxygen therapy. This, along with the rising geriatric population, represents one of the key factors stimulating the oxygen therapy market growth.

Key Market Trends: Home healthcare is the new trend among people suffering from respiratory diseases, as it provides convenience to patients. Hospitals stays are costly, and home healthcare helping in saving money, which makes it highly preferable.

Geographical Trends: North America leads the market because of rising prevalence of respiratory diseases owing to smoking and environmental pollution. However, as elderly population is increasing in the Asia Pacific region, this region is becoming an emerging market for oxygen therapy.

Competitive Landscape: Some of the major market players in the oxygen therapy industry include Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A.,Teleflex Incorporated, among many others.

Challenges and Opportunities: While the market faces challenges, such as limited healthcare access in several regions, it also encounters opportunities in technological advancements like telemedicine integration and remote monitoring capabilities.

Oxygen Therapy Market Trends:

Home Healthcare Trends

The IMARC Group's report shows that the global home healthcare market reached US$ 392.2 Billion in 2023. Many patients, particularly among the elderly and those with chronic diseases, prefer the comfort and convenience of receiving care at home over institutional settings, such as hospitals or nursing homes. This inclination is driving the demand for home oxygen therapy options. Home healthcare is frequently more affordable than inpatient care, lowering hospital stays and associated costs. Home healthcare devices are lightweight, simple to use, and allow patients to preserve their mobility and freedom, making home oxygen therapy more viable and appealing. Many chronic respiratory disorders, including COPD and pulmonary fibrosis, necessitate long-term oxygen treatment. Home healthcare allows for ongoing and consistent management of various illnesses, which improves patient adherence to treatment and outcomes.

Increasing Prevalence of Respiratory Diseases

According to an article published on the website of the World Health Organization (WHO) in 2023, the third leading cause of death worldwide is chronic obstructive pulmonary disease (COPD), causing 3.23 million deaths in 2019. COPD, asthma, interstitial lung disease, and pneumonia is very common and there is a requirement of oxygen therapy for managing the symptoms of these diseases. Because respiratory diseases have harmful impact and only long-term management can help patients treat these conditions, oxygen therapy is highly valuable in maintaining adequate levels of oxygen in the blood while managing chronic respiratory conditions.

Aging Population

Elderly people are more susceptible to respiratory conditions like COPD, emphysema, and pneumonia, and oxygen therapy is the only way to manage these conditions. Old people may have several chronic conditions, such as hypertension, heart disease, diabetes, which can worsen respiratory problems, thereby catalyzing the demand for oxygen therapy. The weak immune system of the geriatric population can attract several infections, which can lead to severe respiratory diseases. An article published on the website of the International Monetary Fund (IMF) eLibrary shows that by 2050 the global share of people aged 80 and older is expected to quadruple to almost 5%.

Oxygen Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end use.

Breakup by Product:

Oxygen Source Equipment

Oxygen Cylinders

Oxygen Concentrators

Liquid Oxygen Devices

PAP Devices

Oxygen Delivery Devices

Oxygen Masks

Nasal Cannula

Venturi Masks

Non-rebreather Masks

Bag Valve Masks

CPAP Masks

Others

Oxygen source equipment accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes oxygen source equipment (oxygen cylinders, oxygen concentrators, liquid oxygen devices, and PAP devices) and oxygen delivery devices (oxygen masks, nasal cannula, venturi masks, non-rebreather masks, bag valve masks, CPAP masks, and others). According to the report, oxygen source equipment represents the largest segment.

Oxygen source equipment is essential for oxygen treatment because it supplies patients with the oxygen they require. Without these devices, it would be hard to provide oxygen to patients in need, making them market essential. These devices are utilized in a variety of contexts, including hospitals, clinics, and home healthcare facilities. Their adaptability and requirement in many healthcare settings are driving their strong demand. Continuous advancements and improvements in oxygen source equipment, such as portable and lightweight designs, better efficiency, and user-friendly features, are influencing the oxygen therapy market overview.

Breakup by Application:

Chronic Obstructive Pulmonary Disease

Asthma

Obstructive Sleep Apnea

Respiratory Distress Syndrome

Cystic Fibrosis

Pneumonia

Others

Chronic obstructive pulmonary disease holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, pneumonia, and others. According to the report, chronic obstructive pulmonary disease accounts for the largest market share.

The high incidence of COPD directly corresponds to a large patient population requiring oxygen therapy, making it the most common application area. COPD is a progressive and chronic ailment that usually worsens with time, demanding long-term care and treatment. Patients with COPD may require continuous or intermittent oxygen therapy to control symptoms and maintain their quality of life. Oxygen treatment alleviates respiratory difficulties and severe shortness of breath, making it an essential part of COPD management, thereby positively influencing the oxygen therapy market insights.

Breakup by End Use:

Home Healthcare

Hospitals

Home healthcare represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end use. This includes home healthcare and hospitals. According to the report, home healthcare represents the largest segment.

Patients prefer to receive care in the comfort of their own homes rather than in hospitals or clinics. Home healthcare enables patients to continue their habits and remain in familiar settings, which can improve their overall quality of life and satisfaction with care. In general, home healthcare costs less than inpatient treatment. It eliminates the need for prolonged hospital stays, lowers healthcare expenses, and eases the pressure on healthcare institutions. This cost-effectiveness appeals to both patients and healthcare professionals. Medical technology advancements, particularly in portable oxygen concentrators and other home-use oxygen delivery systems, have simplified patients' access to oxygen therapy at home. These gadgets have become more user-friendly, efficient, and portable, increasing their attractiveness for home use.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest oxygen therapy market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for oxygen therapy.

North America has a high prevalence of respiratory disorders like COPD, asthma, and sleep apnea, which are caused by factors, such as aging populations, smoking, and environmental pollution. Advanced healthcare infrastructure, widespread availability of cutting-edge medical technologies, and solid healthcare reimbursement regulations all help to drive the market forward. Furthermore, the increasing popularity of home healthcare and the availability of portable and user-friendly oxygen therapy devices make it easier for patients to manage their diseases at home. Moreover, key players operating in this region are focusing on expanding their storage capacities of gases like oxygen. For instance, in 2024 Chart Industries announced the grand opening of its jumbo cryogenic tank manufacturing facility in Theodore, Alabama.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the oxygen therapy industry include Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A.,Teleflex Incorporated, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key companies in the oxygen treatment market are actively involved in a variety of strategic activities aimed at increasing their market presence, improving product offerings, and fulfilling changing customer needs. Oxygen therapy market leaders are investing in research and development (R&D) activities to produce revolutionary oxygen therapy equipment with advanced features, improved portability, and increased efficiency. Furthermore, significant businesses frequently use mergers and acquisitions (M&A), and alliances to boost their product portfolios, expand their geographic reach, and enter new markets. For instance, Chart Industries, Inc., a global leader in engineering and manufacturing of process technology and equipment for industrial gas, specialty and energy transition markets, completed its acquisition of Howden, a leading global provider of mission critical air and gas handling products and services, from affiliates of KPS Capital Partners, LP ("KPS") in 2023. Some businesses are also engaging in marketing and educational initiatives to improve knowledge about respiratory health and the advantages of oxygen treatment.

Oxygen Therapy Market News:

July 2023: Emerson has launched the ASCO(TM) Series 588 Stationary Oxygen Concentrator Manifold, the healthcare industry's first turnkey manifold solution designed to optimize respiratory therapy device designs and accelerate product speed to market.

Key Questions Answered in This Report

  • 1. How big is the global oxygen therapy market?
  • 2. What is the expected growth rate of the global oxygen therapy market during 2024-2032?
  • 3. What are the key factors driving the global oxygen therapy market?
  • 4. What has been the impact of COVID-19 on the global oxygen therapy market?
  • 5. What is the breakup of the global oxygen therapy market based on the product?
  • 6. What is the breakup of the global oxygen therapy market based on the application?
  • 7. What is the breakup of the global oxygen therapy market based on the end use?
  • 8. What are the key regions in the global oxygen therapy market?
  • 9. Who are the key players/companies in the global oxygen therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygen Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oxygen Source Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Oxygen Cylinders
      • 6.1.2.2 Oxygen Concentrators
      • 6.1.2.3 Liquid Oxygen Devices
      • 6.1.2.4 PAP Devices
    • 6.1.3 Market Forecast
  • 6.2 Oxygen Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Oxygen Masks
      • 6.2.2.2 Nasal Cannula
      • 6.2.2.3 Venturi Masks
      • 6.2.2.4 Non-rebreather Masks
      • 6.2.2.5 Bag Valve Masks
      • 6.2.2.6 CPAP Masks
      • 6.2.2.7 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Chronic Obstructive Pulmonary Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Obstructive Sleep Apnea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Distress Syndrome
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cystic Fibrosis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pneumonia
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Home Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allied Healthcare Products Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fisher & Paykel Healthcare Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Getinge AB
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Hersill SL
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Invacare Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smiths Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tecno-Gaz S.p.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teleflex Incorporated
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis